TRU-016
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TRU-016, covering 2016-10-06 to 2017-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's Lymphoma [Phase 1]